Apeiron Labs, Inc. filed a Form D with the Securities and Exchange Commission on 2025-08-19.
Apeiron Labs, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 19, 2025. The filing reports $7.75M sold. Its industry group is Other Technology. It names Ravikanth Pappu (Executive Officer, Director), Sanjeev Krishnan (Director), Kyle Teamey (Director) (SEC Form D, August 19, 2025).
Is this your company?
Sell to companies like Apeiron Labs, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2025-08-19 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Apeiron Labs, Inc.
Free to see. No signup.
More on the people and the money behind Apeiron Labs, Inc., from the filings we hold.
Other Technology raises by companies based in Massachusetts, filed in August 2025, largest first.
Get an email when Apeiron Labs, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Apeiron Labs, Inc. raises, hires or launches. No email unless you switch it on.
Watch Apeiron Labs, Inc. →Get the full cited report on Apeiron Labs, Inc.
What the filing shows about Apeiron Labs, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Apeiron Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Apeiron Labs, Inc.'s address as 486 Green Street, Cambridge, MA 02139.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Apeiron Labs, Inc. is a registered filer with the SEC (CIK 1933295) and has filed since 2025-08-19. 1 filing is on record, the latest on 2025-08-19.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Apeiron Labs, Inc.'s Form D of 2025-08-19 names Ravikanth Pappu, Sanjeev Krishnan, Kyle Teamey and 3 more as its officers, directors or promoters.
Its new offerings report $7.75M sold across 1 offering, as its own filings state.
Trailing twelve months. 3842 filings in Other Technology, totalled by week.
Checked away from the filing. What is below does not come from the record on sec.gov.
The title and description the site itself served, answering 200, after redirecting from https://apeironlabs.com. Not a cached copy and not the company's directory entry — what was live when we asked.
Ravikanth Pappu is named as Executive Officer and Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
Sanjeev Krishnan is named as Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
Kyle Teamey is named as Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
David Douglas is named as Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
Jonathan Rosen is named as Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
Mark Abbott is named as Director on the Form D that Apeiron Labs, Inc. filed with the SEC on 19 August 2025, one of 6 people that filing names.
6 people named on the filing — 1 holding an executive role and 5 as directors only.
Named as of the 2025-08-19 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Apeiron Labs, Inc.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Apeiron Labs, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Apeiron Labs, Inc. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Apeiron Labs, Inc.You get an alert in MentionFox the next time this company shows up.
If you're behind Apeiron Labs, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov, and from the company's own site, read directly on 2026-11-01 (apeironlabs.com).
Each opens in a new tab, filled in for Apeiron Labs, Inc.. With no account yet, you sign up free and land on the result.
On these lists: AI and software raises in Boston
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/apeiron-labs-inc-form-d-25000001